Core Viewpoint - The company, Zhongye Meiliyun Industrial Investment Co., Ltd., has released its 2025 semi-annual report, indicating stable operations and no significant adverse impacts from the liquidation of its subsidiary, Xinghe Technology [5][6]. Company Overview - The company did not distribute cash dividends or issue bonus shares during the reporting period [3]. - The number of shareholders and their holdings remained unchanged, with no changes in the controlling shareholder or actual controller during the reporting period [5]. Financial Data and Key Indicators - The company raised a total of RMB 1,945.30 million through a non-public offering of 378,463,035 shares at RMB 5.14 per share [11]. - As of June 30, 2025, the net amount of raised funds was RMB 1,928.30 million, with total earnings of RMB 141.16 million from investments [12]. - The company has utilized RMB 1,984.69 million of the raised funds, with RMB 1,256.39 million allocated to the data center project and RMB 693.90 million for debt repayment [12][18]. Important Matters - The liquidation of Xinghe Technology is being conducted according to the asset disposal plan approved by the board, and it is not expected to adversely affect the company's operations or financial status [5][6]. - The company has established a management system for the raised funds, ensuring that they are used for their intended purposes and are subject to strict approval processes [13][19]. Risk Assessment - The company conducted a risk assessment of its affiliate, Chengtong Financial Co., Ltd., which has a registered capital of RMB 5 billion and has established a comprehensive internal control system [20][43]. - As of June 30, 2025, Chengtong Financial's capital adequacy ratio was 23.89%, significantly above the regulatory requirement of 10% [37].

Group 1 - The company has received approval from the China Securities Regulatory Commission to issue convertible bonds totaling RMB 1,375 million, with a net amount of RMB 1,359.26 million after deducting issuance costs [2][3] - The company plans to change the use of surplus funds from the bond issuance, amounting to RMB 357.20 million, to invest in a project for an annual production of 2.4 million tons of alumina [3][4] - A tripartite supervision agreement has been signed to regulate the management of the raised funds, involving the company, its subsidiary, and the underwriting institution [4][5] Group 2 - The special account for the raised funds has been established, with a balance of RMB 357.61 million as of June 24, 2025, designated solely for the investment in the alumina project [6][7] - The underwriting institution is responsible for ongoing supervision of the fund usage, ensuring compliance with relevant regulations [7][8] - The agreement stipulates that any withdrawal exceeding RMB 50 million or 20% of the net raised funds must be reported to the underwriting institution [8][9]

Core Points - The company has released its 2025 semi-annual report, which includes financial results and future development plans [1][3] - The board of directors and supervisory board have confirmed the authenticity and completeness of the report [2][7] - The report has not been audited [1] Company Overview - Beijing Fuyuan Pharmaceutical Co., Ltd. is the company in focus, with its stock code being 601089 [1] - The company has not experienced any changes in its controlling shareholder or actual controller during the reporting period [1] Important Matters - The company has not reported any significant changes in its operational situation during the reporting period [1] - The board of directors approved the semi-annual report and its summary, which reflects the company's financial status and operational results [3][4] Fundraising and Usage - The company raised a total of RMB 1,754.4 million from its initial public offering, with a net amount of RMB 1,635.92 million after deducting issuance costs [16][17] - As of June 30, 2025, the company had two fundraising accounts with a total balance of RMB 124.35 million [18][19] - The company has not used idle fundraising for temporary working capital or other purposes during the reporting period [20][22] Fund Management - The company has established a fundraising management system to ensure the proper use and supervision of the funds [18] - A tripartite supervision agreement was signed with the underwriter and banks to regulate the management of the fundraising [18] Changes in Fundraising Projects - The company has made adjustments to some fundraising project implementations based on its actual situation and development strategy [24] - There have been no transfers or replacements of fundraising investment projects during the reporting period [25] Issues in Fund Usage and Disclosure - The company has disclosed information regarding the use of fundraising in a timely and accurate manner, with no violations reported [26]

Group 1 - The company held its second board meeting on August 15, 2025, where several key resolutions were passed, including the approval of the 2025 semi-annual report and its summary [3][15] - The company reported a total fundraising amount of RMB 960.86 million from its initial public offering, with a net amount of RMB 864.08 million after deducting issuance costs [20] - The company has established a special account management system for the raised funds to ensure proper usage and compliance with regulations [21][22] Group 2 - The company approved a resolution to change its business scope, which now includes the sale of smart drones and information system integration services, expanding its operational capabilities [39] - The company plans to hold its third extraordinary general meeting on September 4, 2025, to discuss the resolutions passed by the board, including the changes to the business scope [43][47] - The company has implemented a cash management strategy for temporarily idle raised funds, with a total of RMB 450 million in cash management accounts yielding RMB 537,040 in returns for the first half of 2025 [29][30]

Group 1 - The company, Beijing Jingpin Special Equipment Technology Co., Ltd., issued 19 million shares at a price of 60.98 RMB per share, raising a total of 1,158,620,000 RMB, with a net amount of 1,067,276,861.41 RMB after deducting expenses [4] - As of June 30, 2025, the company has a balance of 180,000,000 RMB in cash management from idle raised funds [12] - The company has not used idle raised funds to temporarily supplement working capital during the reporting period [10] Group 2 - The company has established a management system for raised funds to ensure compliance with relevant laws and regulations [7] - The company has signed tripartite supervision agreements with various banks and its sponsor to manage the raised funds [8] - The company plans to use 90 million RMB of raised funds to increase capital in its wholly-owned subsidiary for a specific project [17] Group 3 - The company has not made any changes to the raised funds investment projects during the reporting period [18] - There were no significant issues or violations in the use and disclosure of raised funds during the reporting period [19] - The company has completed a share buyback of 1,523,639 shares, accounting for 2.0138% of the total share capital, with a total expenditure of 66,532,789.27 RMB [14]

Group 1 - The company will hold its third extraordinary general meeting of shareholders on September 3, 2025, at 14:30 [2][4][58] - The voting will be conducted through a combination of on-site and online voting systems provided by the Shanghai Stock Exchange [4][5][58] - Shareholders must register to attend the meeting, with specific documentation required for both corporate and individual shareholders [11][12][14] Group 2 - The company has returned 90 million RMB of idle raised funds to the special account and plans to use 43.5838 million RMB of remaining over-raised funds for permanent working capital [21][20][52] - The total amount of over-raised funds is 285.268 million RMB, with the current proposal representing 15.28% of this total [21][52] - The company has received a no-objection opinion from its sponsor regarding the use of these funds [22][35] Group 3 - The company has previously used idle raised funds temporarily for working capital, with a total of 90 million RMB returned as of August 18, 2025 [21][44] - The company has a history of using over-raised funds for various projects, including the construction of a polystyrene production facility and expansion of flame retardant production [27][48] - The company has committed to not exceeding 30% of the total over-raised funds for permanent working capital within any twelve-month period [31]

Group 1 - The company has adjusted the maximum repurchase price from 12 RMB per share to 17 RMB per share and extended the implementation period by 6 months, now ending on February 27, 2026 [16][21][36] - The repurchase plan aims to use self-owned funds and may include special loans for stock repurchase [19][20] - As of the disclosure date, the company has repurchased 1,482,364 shares, accounting for 0.731% of the total share capital, with a total expenditure of approximately 14.29 million RMB [20][21] Group 2 - The company raised a total of 845.17 million RMB from the public offering, with a net amount of 750.86 million RMB after deducting various fees [2][4] - The company has established a management system for the raised funds, ensuring they are stored in dedicated accounts and used according to regulatory requirements [4][5] - The company has not encountered any abnormal situations regarding the investment projects funded by the raised capital [7][8]

Core Viewpoint - The report details the fundraising activities and the actual usage of the raised funds by Anhui Xindong Link Micro System Co., Ltd. for the first half of 2025, ensuring compliance with regulatory requirements and highlighting the management of funds [1]. Fundraising Overview - The company raised a total of RMB 1,476.32 million by issuing 55.21 million shares at RMB 26.74 per share, with net proceeds amounting to RMB 1,354.36 million after deducting issuance costs of RMB 121.96 million [1]. - As of June 30, 2025, the actual balance of the raised funds, including interest income, was RMB 928.91 million [3]. Fund Usage and Management - The company has established a dedicated account for the management of raised funds, adhering to the regulations set forth by the relevant authorities [1][4]. - The funds were primarily used for direct investment in projects and to supplement working capital, with RMB 53.76 million directly invested in projects and RMB 73.86 million used to supplement working capital as of June 30, 2025 [2][3]. Cash Management - The company has approved the use of idle raised funds for cash management, with a limit of RMB 1,200 million, ensuring that this does not affect the progress of investment projects [6][8]. - As of June 30, 2025, the company had engaged in cash management activities with a total of RMB 600 million allocated for this purpose [8]. Fund Allocation and Project Status - The company has not changed the use of raised funds for investment projects, and there are no instances of using idle funds temporarily to supplement working capital [9][10]. - The company reported that it has not used any over-raised funds for new projects or to repay bank loans, maintaining compliance with regulatory requirements [9][10]. Compliance and Reporting - The company confirmed that its management and usage of the raised funds comply with the relevant laws and regulations, ensuring that there are no violations or misleading disclosures regarding the use of funds [10][11].

证券代码：688669 证券简称：聚石化学 公告编号：2025-047 广东聚石化学股份有限公司 根据中国证券监督管理委员会出具的《关于同意广东聚石化学股份有限公司 首次公开发行股票注册的批复》（证监许可〔2020〕3569 号），公司获准向社 会公开发行人民币普通股 2,333.3334 万股，每股面值人民币 1.00 元，每股发行 价为人民币 36.65 元，合计募集资金人民币 85,516.67 万元，扣除发行费用人民 币 7,943.70 万元（不含增值税），募集资金净额为人民币 77,572.97 万元。上述 募集资金已于 2021 年 1 月 19 日全部到位，立信会计师事务所（特殊普通合伙） 于 2021 年 1 月 19 日对资金到位情况进行了审验，并出具了《验资报告》（信会 师报字[2021]第 ZE10005 号）。 关于归还临时用于补充流动资金的闲置募集资金及 使用剩余超募资金永久补充流动资金的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 截至 2025 年 8 月 18 日， ...

Fundraising Overview - The company raised a total of RMB 717 million from the issuance of 30 million shares at RMB 23.90 per share, with a net amount of RMB 648.33 million after deducting issuance costs [1] - As of June 30, 2025, the company had a remaining balance of RMB 7.30 million in its fundraising account [3] Fund Management - The company has established a management system for fundraising in accordance with regulatory guidelines to ensure proper use and protection of investor rights [1] - A tripartite supervision agreement was signed with the underwriter and banks to ensure the funds are used specifically for their intended purposes [2][3] Fund Utilization - The company completed the investment projects related to the expansion of microbial oil and polyunsaturated fatty acid microencapsulation production lines in 2023, with final payments made during the reporting period [4][5] - The research center construction project has fully utilized the committed fundraising amount, with excess funding derived from interest income [4][8] Financial Management - The company has not used any excess fundraising to permanently supplement working capital or repay bank loans during the reporting period [5][6] - The board approved the temporary use of up to RMB 12 million of idle funds for cash management, ensuring it does not affect ongoing projects [5] Compliance and Reporting - The company has adhered to all relevant laws and regulations regarding the use of fundraising and has disclosed the usage status in a timely manner [7]